Sariel Diagnostics Corp. announces a private placement of 3,750,000 common shares will issue at price of CAD 0.02 per share for gross proceeds of CAD 75,000 on March 5, 2024. The transaction will include participation from new investor, ThreeD Capital Inc. The transaction remains subject to the approval of the Canadian Securities Exchange.